SLC17A1/3 transporters mediate renal excretion of Lac-Phe in mice and humans.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
12 Aug 2024
Historique:
received: 13 11 2023
accepted: 01 08 2024
medline: 13 8 2024
pubmed: 13 8 2024
entrez: 12 8 2024
Statut: epublish

Résumé

N-lactoyl-phenylalanine (Lac-Phe) is a lactate-derived metabolite that suppresses food intake and body weight. Little is known about the mechanisms that mediate Lac-Phe transport across cell membranes. Here we identify SLC17A1 and SLC17A3, two kidney-restricted plasma membrane-localized solute carriers, as physiologic urine Lac-Phe transporters. In cell culture, SLC17A1/3 exhibit high Lac-Phe efflux activity. In humans, levels of Lac-Phe in urine exhibit a strong genetic association with the SLC17A1-4 locus. Urine Lac-Phe levels are increased following a Wingate sprint test. In mice, genetic ablation of either SLC17A1 or SLC17A3 reduces urine Lac-Phe levels. Despite these differences, both knockout strains have normal blood Lac-Phe and body weights, demonstrating SLC17A1/3-dependent de-coupling of urine and plasma Lac-Phe pools. Together, these data establish SLC17A1/3 family members as the physiologic urine Lac-Phe transporters and uncover a biochemical pathway for the renal excretion of this signaling metabolite.

Identifiants

pubmed: 39134528
doi: 10.1038/s41467-024-51174-3
pii: 10.1038/s41467-024-51174-3
doi:

Substances chimiques

Lactates 0
Phenylalanine 47E5O17Y3R
N-lactoyl-phenylalanine 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

6895

Subventions

Organisme : U.S. Department of Health & Human Services | National Institutes of Health (NIH)
ID : DK124265
Organisme : U.S. Department of Health & Human Services | National Institutes of Health (NIH)
ID : DK136526
Organisme : U.S. Department of Health & Human Services | National Institutes of Health (NIH)
ID : P30DK116074
Organisme : U.S. Department of Health & Human Services | National Institutes of Health (NIH)
ID : GM113854
Organisme : Deutsche Forschungsgemeinschaft (German Research Foundation)
ID : 431984000

Informations de copyright

© 2024. The Author(s).

Références

Rabinowitz, J. D. & Enerbäck, S. Lactate: the ugly duckling of energy metabolism. Nat. Metab. 2, 566–571 (2020).
doi: 10.1038/s42255-020-0243-4 pubmed: 32694798 pmcid: 7983055
Brooks, G. A. Lactate as a fulcrum of metabolism. Redox Biol. 35, 101454 (2020).
doi: 10.1016/j.redox.2020.101454 pubmed: 32113910 pmcid: 7284908
Gladden, L. B. Lactate metabolism: A new paradigm for the third millennium. J. Physiol. 558, 5–30 (2004).
doi: 10.1113/jphysiol.2003.058701 pubmed: 15131240 pmcid: 1664920
Brooks, G. A. et al. Lactate as a major myokine and exerkine. Nat. Rev. Endocrinol. 18, 712 (2022).
doi: 10.1038/s41574-022-00724-0 pubmed: 35915256
Liu, C. et al. Lactate inhibits lipolysis in fat cells through activation of an orphan G-protein-coupled receptor, GPR81. J. Biol. Chem. 284, 2811–2822 (2009).
doi: 10.1074/jbc.M806409200 pubmed: 19047060
Zaborska, K. E. et al. Lactate activation of α-cell KATP channels inhibits glucagon secretion by hyperpolarizing the membrane potential and reducing Ca2+ entry. Mol. Metab. 42, 101056 (2020).
doi: 10.1016/j.molmet.2020.101056 pubmed: 32736089 pmcid: 7479281
Hollnagel, J. O. et al. Lactate Attenuates Synaptic Transmission and Affects Brain Rhythms Featuring High Energy Expenditure. iScience 23, 101316 (2020).
doi: 10.1016/j.isci.2020.101316 pubmed: 32653807 pmcid: 7350153
Zhang, D. et al. Metabolic regulation of gene expression by histone lactylation. Nature 574, 575–580 (2019).
doi: 10.1038/s41586-019-1678-1 pubmed: 31645732 pmcid: 6818755
Li, V. L. et al. An exercise-inducible metabolite that suppresses feeding and obesity. Nature 606, 785–790 (2022).
doi: 10.1038/s41586-022-04828-5 pubmed: 35705806 pmcid: 9767481
Xiao, S. et al. Lac-Phe mediates the effects of metformin on food intake and body weight. Nat. Metab. 2024 6, 659–669 (2024).
doi: 10.1038/s42255-024-00999-9
Scott, B. et al. Metformin and feeding increase levels of the appetite-suppressing metabolite Lac-Phe in humans. Nat. Metab. 6, 651–658 (2024).
doi: 10.1038/s42255-024-01018-7 pubmed: 38499765 pmcid: 11052712
Jansen, R. S. et al. N -lactoyl-amino acids are ubiquitous metabolites that originate from CNDP2-mediated reverse proteolysis of lactate and amino acids. Proc. Natl Acad. Sci. 112, 6601–6606 (2015).
doi: 10.1073/pnas.1424638112 pubmed: 25964343 pmcid: 4450436
Hoene, M. et al. Exercise-Induced N-Lactoylphenylalanine Predicts Adipose Tissue Loss during Endurance Training in Overweight and Obese Humans. Metabolites 13, 15 (2022).
doi: 10.3390/metabo13010015 pubmed: 36676940 pmcid: 9863672
Schlosser, P. et al. Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans. Nat. Genet 52, 167–176 (2020).
doi: 10.1038/s41588-019-0567-8 pubmed: 31959995 pmcid: 7484970
Schlosser, P. et al. Genetic studies of paired metabolomes reveal enzymatic and transport processes at the interface of plasma and urine. Nat. Genet 55, 995–1008 (2023).
doi: 10.1038/s41588-023-01409-8 pubmed: 37277652 pmcid: 10260405
Otani, N., Ouchi, M., Hayashi, K., Jutabha, P. & Anzai, N. Roles of organic anion transporters (OATs) in renal proximal tubules and their localization. Anat. Sci. Int. 92, 200–206 (2017).
doi: 10.1007/s12565-016-0369-3 pubmed: 27614971
Togawa, N., Miyaji, T., Izawa, S., Omote, H. & Moriyama, Y. A Na+-phosphate cotransporter homologue (SLC17A4 protein) is an intestinal organic anion exporter. Am. J. Physiol. Cell Physiol. 302, 1652–1660 (2012).
doi: 10.1152/ajpcell.00015.2012
Iharada, M. et al. Type 1 sodium-dependent phosphate transporter (SLC17A1 protein) is a Cl–dependent urate exporter. J. Biol. Chem. 285, 26107–26113 (2010).
doi: 10.1074/jbc.M110.122721 pubmed: 20566650 pmcid: 2924012
Smith, C. A., Want, E. J., O’Maille, G., Abagyan, R. & Siuzdak, G. XCMS: Processing mass spectrometry data for metabolite profiling using nonlinear peak alignment, matching, and identification. Anal. Chem. 78, 779–787 (2006).
doi: 10.1021/ac051437y pubmed: 16448051
Lonsdale, J. et al. The Genotype-Tissue Expression (GTEx) project. Nat. Genet 45, 580–585 (2013).
doi: 10.1038/ng.2653
Wu, C. et al. BioGPS: An extensible and customizable portal for querying and organizing gene annotation resources. Genome Biol. 10, R130 (2009).
doi: 10.1186/gb-2009-10-11-r130 pubmed: 19919682 pmcid: 3091323
Skarnes, W. C. et al. A conditional knockout resource for the genome-wide study of mouse gene function. Nature 474, 337–344 (2011).
doi: 10.1038/nature10163 pubmed: 21677750 pmcid: 3572410
Dehghan, A. et al. Association of three genetic loci with uric acid concentration and risk of gout: a genome-wide association study. Lancet 372, 1953–1961 (2008).
doi: 10.1016/S0140-6736(08)61343-4 pubmed: 18834626 pmcid: 2803340
Woodward, O. M. et al. Identification of a urate transporter, ABCG2, with a common functional polymorphism causing gout. Proc. Natl Acad. Sci. USA 106, 10338–10342 (2009).
doi: 10.1073/pnas.0901249106 pubmed: 19506252 pmcid: 2700910
Kratzer, J. T. et al. Evolutionary history and metabolic insights of ancient mammalian uricases. Proc. Natl Acad. Sci. USA 111, 3763–3768 (2014).
doi: 10.1073/pnas.1320393111 pubmed: 24550457 pmcid: 3956161
Morville, T., Sahl, R. E., Moritz, T., Helge, J. W. & Clemmensen, C. Plasma Metabolome Profiling of Resistance Exercise and Endurance Exercise in Humans. Cell Rep. 33, 108554 (2020).
doi: 10.1016/j.celrep.2020.108554 pubmed: 33378671
Chiba, T. et al. NPT1/SLC17A1 is a renal urate exporter in humans and its common gain-of-function variant decreases the risk of renal underexcretion gout. Arthritis Rheumatol. 67, 281–287 (2015).
doi: 10.1002/art.38884 pubmed: 25252215
Jutabha, P. et al. Human sodium phosphate transporter 4 (hNPT4/SLC17A3) as a common renal secretory pathway for drugs and urate. J. Biol. Chem. 285, 35123–35132 (2010).
doi: 10.1074/jbc.M110.121301 pubmed: 20810651 pmcid: 2966126

Auteurs

Veronica L Li (VL)

Department of Pathology, Stanford University School of Medicine, Stanford, CA, USA.
Department of Chemistry, Stanford University, Stanford, CA, USA.
Sarafan ChEM-H, Stanford University, Stanford, CA, USA.
Stanford Diabetes Research Center, Stanford University, Stanford, CA, USA.

Shuke Xiao (S)

Department of Pathology, Stanford University School of Medicine, Stanford, CA, USA.
Sarafan ChEM-H, Stanford University, Stanford, CA, USA.
Stanford Diabetes Research Center, Stanford University, Stanford, CA, USA.

Pascal Schlosser (P)

Institute of Genetic Epidemiology, Faculty of Medicine and Medical Center, University of Freiburg, Freiburg, Germany.
Department of Epidemiology, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD, USA.
Centre for Integrative Biological Signaling Studies (CIBSS), University of Freiburg, Freiburg, Germany.

Nora Scherer (N)

Institute of Genetic Epidemiology, Faculty of Medicine and Medical Center, University of Freiburg, Freiburg, Germany.
Spemann Graduate School of Biology and Medicine (SGBM), University of Freiburg, Freiburg, Germany.

Amanda L Wiggenhorn (AL)

Department of Pathology, Stanford University School of Medicine, Stanford, CA, USA.
Department of Chemistry, Stanford University, Stanford, CA, USA.
Sarafan ChEM-H, Stanford University, Stanford, CA, USA.
Stanford Diabetes Research Center, Stanford University, Stanford, CA, USA.

Jan Spaas (J)

Department of Pathology, Stanford University School of Medicine, Stanford, CA, USA.
Sarafan ChEM-H, Stanford University, Stanford, CA, USA.
Stanford Diabetes Research Center, Stanford University, Stanford, CA, USA.

Alan Sheng-Hwa Tung (AS)

Department of Pathology, Stanford University School of Medicine, Stanford, CA, USA.
Sarafan ChEM-H, Stanford University, Stanford, CA, USA.
Stanford Diabetes Research Center, Stanford University, Stanford, CA, USA.

Edward D Karoly (ED)

Metabolon, Inc., Morrisville, NC, USA.

Anna Köttgen (A)

Institute of Genetic Epidemiology, Faculty of Medicine and Medical Center, University of Freiburg, Freiburg, Germany.
Department of Epidemiology, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD, USA.
Centre for Integrative Biological Signaling Studies (CIBSS), University of Freiburg, Freiburg, Germany.

Jonathan Z Long (JZ)

Department of Pathology, Stanford University School of Medicine, Stanford, CA, USA. jzlong@stanford.edu.
Sarafan ChEM-H, Stanford University, Stanford, CA, USA. jzlong@stanford.edu.
Stanford Diabetes Research Center, Stanford University, Stanford, CA, USA. jzlong@stanford.edu.
The Phil & Penny Knight Initiative for Brain Resilience at the Wu Tsai Neurosciences Institute, Stanford University, Stanford, CA, USA. jzlong@stanford.edu.
Stanford Cardiovascular Institute, Stanford University, Stanford, CA, USA. jzlong@stanford.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH